Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

HIV infection is influenced by dynamin at three independent points in the viral life cycle.

Aggarwal A, Hitchen TL, Ootes L, McAllery S, Wong A, Nguyen K, McCluskey A, Robinson PJ, Turville SG.

Traffic. 2017 Mar 21. doi: 10.1111/tra.12481. [Epub ahead of print]

PMID:
28321960
2.

Small molecule Hedgehog pathway antagonists.

Trinh TN, McLaughlin EA, Gordon CP, Bernstein IR, Pye VJ, Redgrove KA, McCluskey A.

Org Biomol Chem. 2017 Mar 20. doi: 10.1039/c6ob01959e. [Epub ahead of print]

PMID:
28318003
3.

Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells.

Zahaf NI, Lang AE, Kaiser L, Fichter CD, Lassmann S, McCluskey A, Augspach A, Aktories K, Schmidt G.

Sci Rep. 2017 Jan 27;7:41252. doi: 10.1038/srep41252.

4.

Structure and feasibility of extra practice during stroke rehabilitation: A systematic scoping review.

Stewart C, McCluskey A, Ada L, Kuys S.

Aust Occup Ther J. 2017 Jan 10. doi: 10.1111/1440-1630.12351. [Epub ahead of print] Review.

PMID:
28071808
5.

Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.

Odell LR, Abdel-Hamid MK, Hill TA, Chau N, Young KA, Deane FM, Sakoff JA, Andersson S, Daniel JA, Robinson PJ, McCluskey A.

J Med Chem. 2017 Jan 12;60(1):349-361. doi: 10.1021/acs.jmedchem.6b01422.

PMID:
27997171
6.

Identification and validation of small molecule modulators of the NusB-NusE interaction.

Cossar PJ, Ma C, Gordon CP, Ambrus JI, Lewis PJ, McCluskey A.

Bioorg Med Chem Lett. 2017 Jan 15;27(2):162-167. doi: 10.1016/j.bmcl.2016.11.091.

PMID:
27964882
7.

Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.

Spare LK, Falsetta P, Gilbert J, Harman DG, Baker MA, Li F, McCluskey A, Clegg JK, Sakoff JA, Aldrich-Wright JR, Gordon CP.

ChemMedChem. 2017 Jan 20;12(2):130-145. doi: 10.1002/cmdc.201600573.

PMID:
27921386
8.

5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors.

Robertson MJ, Horatscheck A, Sauer S, von Kleist L, Baker JR, Stahlschmidt W, Nazaré M, Whiting A, Chau N, Robinson PJ, Haucke V, McCluskey A.

Org Biomol Chem. 2016 Nov 29;14(47):11266-11278.

PMID:
27853797
9.

Validity, reliability and ease of use of the disabilities of arm, shoulder and hand questionnaire in adults following stroke.

Dalton E, Lannin NA, Laver K, Ross L, Ashford S, McCluskey A, Cusick A.

Disabil Rehabil. 2016 Oct 21:1-8. [Epub ahead of print]

PMID:
27767374
10.

Dynamin 2 is essential for mammalian spermatogenesis.

Redgrove KA, Bernstein IR, Pye VJ, Mihalas BP, Sutherland JM, Nixon B, McCluskey A, Robinson PJ, Holt JE, McLaughlin EA.

Sci Rep. 2016 Oct 11;6:35084. doi: 10.1038/srep35084.

11.

Recapping CAPs: The past 13 years of Critically Appraised Papers.

Cordier R, McCluskey A.

Aust Occup Ther J. 2016 Oct;63(5):357-358. doi: 10.1111/1440-1630.12329. No abstract available.

PMID:
27714865
12.

A facile hybrid 'flow and batch' access to substituted 3,4-dihydro-2H-benzo[b][1,4]oxazinones.

Lin AJ, Russell CC, Baker JR, Frailey SL, Sakoff JA, McCluskey A.

Org Biomol Chem. 2016 Sep 21;14(37):8732-8742.

PMID:
27714138
13.

Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitors.

Trinh TN, McLaughlin EA, Abdel-Hamid MK, Gordon CP, Bernstein IR, Pye V, Cossar P, Sakoff JA, McCluskey A.

Org Biomol Chem. 2016 Jul 14;14(26):6304-15. doi: 10.1039/c6ob00606j.

PMID:
27272335
14.

Effect of affordable technology on physical activity levels and mobility outcomes in rehabilitation: a protocol for the Activity and MObility UsiNg Technology (AMOUNT) rehabilitation trial.

Hassett L, van den Berg M, Lindley RI, Crotty M, McCluskey A, van der Ploeg HP, Smith ST, Schurr K, Killington M, Bongers B, Howard K, Heritier S, Togher L, Hackett M, Treacy D, Dorsch S, Wong S, Scrivener K, Chagpar S, Weber H, Pearson R, Sherrington C.

BMJ Open. 2016 Jun 6;6(6):e012074. doi: 10.1136/bmjopen-2016-012074.

15.

Older adults experience difficulty completing the lines and dots tasks of the Motor Assessment Scale.

Dettrick-Janes M, McCluskey A, Lannin NA, Scanlan JN.

Scand J Occup Ther. 2016 May 26:1-9. doi: 10.1080/11038128.2016.1187202. [Epub ahead of print]

PMID:
27228182
16.

Type VI secretion system sheaths as nanoparticles for antigen display.

Del Tordello E, Danilchanka O, McCluskey AJ, Mekalanos JJ.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3042-7. doi: 10.1073/pnas.1524290113.

17.

A behavior change program to increase outings delivered during therapy to stroke survivors by community rehabilitation teams: The Out-and-About trial.

McCluskey A, Ada L, Kelly PJ, Middleton S, Goodall S, Grimshaw JM, Logan P, Longworth M, Karageorge A.

Int J Stroke. 2016 Jun;11(4):425-37. doi: 10.1177/1747493016632246.

PMID:
26906448
18.

Robenidine Analogues as Gram-Positive Antibacterial Agents.

Abraham RJ, Stevens AJ, Young KA, Russell C, Qvist A, Khazandi M, Wong HS, Abraham S, Ogunniyi AD, Page SW, O'Handley R, McCluskey A, Trott DJ.

J Med Chem. 2016 Mar 10;59(5):2126-38. doi: 10.1021/acs.jmedchem.5b01797.

PMID:
26765953
19.

Cytotoxic compounds from Laurencia pacifica.

Zaleta-Pinet DA, Holland IP, Muñoz-Ochoa M, Murillo-Alvarez JI, Sakoff JA, van Altena IA, McCluskey A.

Org Med Chem Lett. 2014 Dec;4(1):8. doi: 10.1186/s13588-014-0008-8.

20.

Emulsion technologies for multicellular tumour spheroid radiation assays.

McMillan KS, McCluskey AG, Sorensen A, Boyd M, Zagnoni M.

Analyst. 2016 Jan 7;141(1):100-10. doi: 10.1039/c5an01382h.

PMID:
26456100

Supplemental Content

Loading ...
Support Center